Altman and Amodei skip Australia's hearing in person
Why I called it
The Senate's request is written and not a compulsory summons, and frontier-lab chief executives facing an incident inquiry have consistently sent policy executives or written submissions rather than testifying themselves. The Medicare breach is more serious than the inquiries either company has faced this way before, which cuts the other direction and keeps this a genuine test rather than a safe bet.
The call, in full. Neither Sam Altman nor Dario Amodei personally appears, in person or by live video testimony, before the Australian Senate AI inquiry's Canberra hearing scheduled for October 1st 2026.
Scoring criterion. RESOLVES WRONG if either Sam Altman or Dario Amodei personally appears, in person or by live video testimony, before the Australian Senate AI inquiry's Canberra hearing held on or about October 1st 2026, per parliamentary records or credible reporting. RESOLVES CORRECT otherwise.
The criterion is the machine-checkable version: a prediction that cannot be settled by a third party against a public source fails the build before it reaches this page.
Related
- Two more lab spin-outs of the Discovery Loop shape · 75%, open
- Palantir hits its raised FY2026 guidance · 80%, open
- A major breach names prompt injection as a root cause · 75%, open